본문 바로가기
KERD
논문KCI 등재

중증 질환에서 호르몬의 변화

Hormonal Changes in Critical Condition

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

When disease or trauma progresses to a critical state, the reaction of the endocrine system in creating homeostasis is essential for survival. The association between the severity of hormonal changes and outcome in terms of morbidity and mortality has led to the challenge of development of several endocrine treatments. During sepsis, nitric oxide-mediated apoptosis is observed in the neurons and glial cells of the cerebrovascular centers of the autonomic nervous system. It is probably one of the components of the circulatory dysfunction of sepsis. The regulation of different organs was neither linear nor independent however organs were found to behave as biological oscillators coupled to each other through neurological or hormonal communication pathways. Sepsis, because of systemic inflammatory responsive syndrome, disrupts these communication pathways and leads to organ failures. Endocrine hormonal issues related to the intensive care setting are common challenges to ICU specialists. Disruptions of the endocrine system in sepsis are characterized by 1) an increase in cortisol plasma levels with a loss of the circadian rhythm of its secretion; 2) hyperglycemia due to insulin resistance and rise in hyperglycemic hormones secretion; 3)relative vasopressin deficiency; and 4) euthyroid sick syndrome or non-thyroidal illness syndrome. This article discusses the dynamic changes of four main endocrine axes: hypothalamic-pituitary-adrenal axis, insulin, vasopressin and thyroid during grave states of disease, when a patient is in critical condition.

Abstract

When disease or trauma progresses to a critical state, the reaction of the endocrine system in creating homeostasis is essential for survival. The association between the severity of hormonal changes and outcome in terms of morbidity and mortality has led to the challenge of development of several endocrine treatments. During sepsis, nitric oxide-mediated apoptosis is observed in the neurons and glial cells of the cerebrovascular centers of the autonomic nervous system. It is probably one of the components of the circulatory dysfunction of sepsis. The regulation of different organs was neither linear nor independent however organs were found to behave as biological oscillators coupled to each other through neurological or hormonal communication pathways. Sepsis, because of systemic inflammatory responsive syndrome, disrupts these communication pathways and leads to organ failures. Endocrine hormonal issues related to the intensive care setting are common challenges to ICU specialists. Disruptions of the endocrine system in sepsis are characterized by 1) an increase in cortisol plasma levels with a loss of the circadian rhythm of its secretion; 2) hyperglycemia due to insulin resistance and rise in hyperglycemic hormones secretion; 3)relative vasopressin deficiency; and 4) euthyroid sick syndrome or non-thyroidal illness syndrome. This article discusses the dynamic changes of four main endocrine axes: hypothalamic-pituitary-adrenal axis, insulin, vasopressin and thyroid during grave states of disease, when a patient is in critical condition.

참고문헌 (66)

  1. Vanhorebeek I, "The neuroendocrine response to critical illness is a dynamic process", Crit Care Clin, 22, pp.1~15 (2006)
  2. Schein RM, "Plasma cortisol levels in patients with septic shock", Crit Care Med, 18, pp.259~263 (1990)
  3. Slag MF, "Hypothyroxinemia in critically ill patients as a predictor of high mortality", JAMA, 245, pp.43~45 (1981)
  4. Landry DW, "Vasopressin deficiency contributes to the vasodilation of septic shock", Circulation, 95, pp.1122~1125 (1997)
  5. Cooper MS, "Corticosteroid insufficiency in acutely ill patients", N Engl J Med, 348, pp.727~734 (2003)
  6. Burchard K, "A review of the adrenal cortex and severe inflammation: quest of the “eucorticoid” state", J Trauma, 51, pp.800~814 (2001)
  7. Rivier C, "Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin", Nature, 305, pp.325~327 (1983)
  8. Marik PE, "Adrenal insufficiency in the critically ill: a new look at an old problem", Chest, 122, pp.1784~1796 (2002)
  9. Pemberton PA, "Hormone binding globulins undergo serpin conformational change in inflammation", Nature, 336, pp.257~258 (1988)
  10. Hammond GL, "A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils", J Clin Endocrinol Metab, 71, pp.34~39 (1990)
  11. Beishuizen A, "Patterns of corticosteroid- binding globulin and the free cortisol index during septic shock and multitrauma", Intensive Care Med, 27, pp.1584~1591 (2001)
  12. Hamrahian AH, "Measurements of serum free cortisol in critically ill patients", N Engl J Med, 350, pp.1629~1638 (2004)
  13. Finlay WE, "Serum cortisol levels in severely stressed patients", Lancet, 1, pp.1414~1415 (1982)
  14. Rothwell PM, "Cortisol response to corticotropin and survival in septic shock", Lancet, 337, pp.582~583 (1991)
  15. Marik PE, "Critical illness-related corticosteroid insufficiency", Chest, 135, pp.181~193 (2009)
  16. Bornstein SR, "Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs", J Clin Endocrinol Metab, 84, pp.1729~1736 (1999)
  17. Vermes I, "The hypothalamic-pituitary-adrenal response to critical illness", Best Pract Res Clin Endocrinol Metab, 15, pp.495~511 (2001)
  18. Cohen J, "Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population", Intensive Care Med, 32, pp.1901~1905 (2006)
  19. Venkatesh B, "Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study", Anaesth Intensive Care, 33, pp.201~209 (2005)
  20. Annane D, "A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin", JAMA, 283, pp.1038~1045 (2000)
  21. Marik PE, "Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine", Crit Care Med, 36, pp.1937~1949 (2008)
  22. Dellinger RP, "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008", Crit Care Med, 36, pp.296~327 (2008)
  23. Yen PM, "Physiological and molecular basis of thyroid hormone action", Physiol Rev, 81, pp.1097~1142 (2001)
  24. Bianco AC, "Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases", Endocr Rev, 23, pp.38~89 (2002)
  25. Friesema EC, "Thyroid hormone transporters", Biochem Soc Trans, 33, pp.228~232 (2005)
  26. Chopra IJ, "Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3'-triiodothyronine in sera of patients with nonthyroidal illnesses", J Clin Endocrinol Metab, 60, pp.666~672 (1985)
  27. Michalaki M, "Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery", J Clin Endocrinol Metab, 86, pp.4198~4205 (2001)
  28. Rothwell PM, "Prediction of outcome in intensive care patients using endocrine parameters", Crit Care Med, 23, pp.78~83 (1995)
  29. McIver B, "Euthyroid sick syndrome: an overview", Thyroid, 7, pp.125~132 (1997)
  30. Van den Berghe G, "Novel insights into the neuroendocrinology of critical illness", Eur J Endocrinol, 143, pp.1~13 (2000)
  31. Romijn JA, "Decreased nocturnal surge of thyrotropin in nonthyroidal illness", J Clin Endocrinol Metab, 70, pp.35~42 (1990)
  32. Bartalena L, "Lack of nocturnal serum thyrotropin surge after surgery", J Clin Endocrinol Metab, 70, pp.293~296 (1990)
  33. Van den Berghe G, "Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues", Clin Endocrinol (Oxf), 47, pp.599~612 (1997)
  34. Van den Berghe G, "Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone- releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness", J Clin Endocrinol Metab, 84, pp.1311~1323 (1999)
  35. Peeters RP, "Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients", J Clin Endocrinol Metab, 88, pp.3202~3211 (2003)
  36. Peeters RP, "Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity", J Clin Endocrinol Metab, 90, pp.6460~6465 (2005)
  37. Umpierrez GE, "Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes", J Clin Endocrinol Metab, 87, pp.978~982 (2002)
  38. Frankenfield DC, "Correlation between measured energy expenditure and clinically obtained variables in trauma and sepsis patients", JPEN J Parenter Enteral Nutr, 18, pp.398~403 (1994)
  39. Perner A, "High glucose impairs superoxide production from isolated blood neutrophils", Intensive Care Med, 29, pp.642~645 (2003)
  40. Khaodhiar L, "Perioperative hyperglycemia, infection or risk?", Curr Opin Clin Nutr Metab Care, 2, pp.79~82 (1999)
  41. Marfella R, "The effect of acute hyperglycaemia on QTc duration in healthy man", Diabetologia, 43, pp.571~575 (2000)
  42. Nilsson P, "Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: the Malm? Preventive Project", J Intern Med, 253, pp.136~145 (2003)
  43. Capes SE, "Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview", Lancet, 355, pp.773~778 (2000)
  44. Hotamisligil GS, "Tumor necrosis factor alpha: a key component of the obesity-diabetes link", Diabetes, 43, pp.1271~1278 (1994)
  45. Van der Poll T, "Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans", Am J Physiol, 261, pp.E457~465 (1991)
  46. van den Berghe G, "Intensive insulin therapy in the critically ill patients", N Engl J Med, 345, pp.1359~1367 (2001)
  47. Van den Berghe G, "Intensive insulin therapy in the medical ICU", N Engl J Med, 354, pp.449~461 (2006)
  48. Landry DW, "Vasopressin pressor hypersensitivity in vasodilatory septic shock", Crit Care Med, 25, pp.1279~1282 (1997)
  49. Langouche L, "Intensive insulin therapy protects the endothelium of critically ill patients", J Clin Invest, 115, pp.2277~2286 (2005)
  50. Sharshar T, "Circulating vasopressin levels in septic shock", Crit Care Med, 31, pp.1752~1758 (2003)
  51. Dünser MW, "Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors", Crit Care Med, 31, pp.1394~1398 (2003)
  52. Hindmarsh PC, "A sexually dimorphic pattern of growth hormone secretion in the elderly", J Clin Endocrinol Metab, 84, pp.2679~2685 (1999)
  53. Van den Berghe G, "A paradoxical gender dissociation within the growth hormone", insulin-like growth factor I axis during protracted critical illness, 2000, pp.85, 183~192
  54. Baxter RC, "Changes in the IGF-IGFBP axis in critical illness", Best Pract Res Clin Endocrinol Metab, 15, pp.421~434 (2001)
  55. Ross R, "Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I", Clin Endocrinol (Oxf), 35, pp.47~54 (1991)
  56. Spratt DI, "Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated?", Best Pract Res Clin Endocrinol Metab, 15, pp.479~494 (2001)
  57. Wolfe R, "Testosterone and muscle protein metabolism", Mayo Clin Proc, 75(Suppl), pp.S55~59 (2000)
  58. Ben-Jonathan N, "Dopamine: a prolactin-inhibiting hormone", Endocr Rev, 6, pp.564~589 (1985)
  59. Russell DH, "Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine", J Immunol, 134, pp.3027~3031 (1985)
  60. Russell DH, "New aspects of prolactin and immunity: a lymphocyte- derived prolactin-like product and nuclear protein kinase C activation", Trends Pharmacol Sci, 10, pp.40~44 (1989)
  61. Bernton EW, "Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice", Science, 239, pp.401~404 (1988)
  62. Wang C, "Effect of surgical stress on pituitary- testicular function", Clin Endocrinol (Oxf), 9, pp.255~266 (1978)
  63. Wang C, "Effect of acute myocardial infarction on pituitary-testicular function", Clin Endocrinol (Oxf), 9, pp.249~253 (1978)
  64. Dong Q, "Circulating immunoreactive inhibin and testosterone levels in men with critical illness", Clin Endocrinol (Oxf), 36, pp.399~404 (1992)
  65. Van den Berghe G, "Dynamic neuroendocrine responses to critical illness", Front Neuroendocrinol, 23, pp.370~391 (2002)
  66. Noel GL, "Human prolactin and growth hormone release during surgery and other conditions of stress", J Clin Endocrinol Metab, 35, pp.840~851 (1972)

관련 논문AI추천

이 간행물의 다른 논문 (16건)